ClinicalTrials.Veeva

Menu
S

Stride Clinical Research | Sugar Land, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SCD-044
Apremilast
PP405
Upadacitinib
Dupilumab
IMG-007

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 6 total trials

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 1...

Active, not recruiting
Plaque Psoriasis
Drug: Apremilast

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Enrolling
Atopic Dermatitis
Drug: Upadacitinib 30mg Dose
Drug: Upadacitinib 15mg Dose

This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.

Active, not recruiting
Moderate to Severe Plaque Psoriasis
Drug: Placebo
Drug: SCD-044_Dose 3

Trial sponsors

Sun Pharma logo
AbbVie logo
Amgen logo
I
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems